首页> 外文期刊>Revista Brasileira de Ortopedia >Use of glucosamine and chondroitin to treat osteoarthritis: a review of the literature
【24h】

Use of glucosamine and chondroitin to treat osteoarthritis: a review of the literature

机译:使用氨基葡萄糖和软骨素治疗骨关节炎:文献综述

获取原文
           

摘要

To evaluate the current evidence that support or disprove the use of glucosamine and chondroitin in the treatment of patients with osteoarthritis. We performed a literature review using the databases of Medline, PubMed and the Cochrane Controlled Trial Register and Cochrane Databases Systematic Reviews (Cochrane Library).We considered only studies with high level of evidence.The study included analysis of randomized controlled trials that included at least 100 patients in each intervention group, meta-analyzes and systematic reviews. Seven meta-analysis, one systematic review and five randomized clinical trials fit inclusion criteria of this review. Considering the best evidences until now, the use of glucosamine and chondroitin does not provide clinical relevant benefits to patients with osteoarthritis of the knee or hip (Level I of evidence and grade A of recommendation). Further trials with adequate technology are necessaries to elucidate this question.
机译:评估支持或反对使用氨基葡萄糖和软骨素治疗骨关节炎患者的当前证据。我们使用Medline,PubMed和Cochrane对照试验注册资料库以及Cochrane数据库系统评价数据库(Cochrane图书馆)进行了文献综述,仅考虑了证据充分的研究,包括对随机对照试验的分析,至少包括每个干预组中有100名患者,进行荟萃分析和系统评价。七项荟萃分析,一项系统评价和五项随机临床试验均符合该评价的纳入标准。考虑到目前为止的最佳证据,使用氨基葡萄糖和软骨素不能为膝或髋骨关节炎患者提供临床相关的益处(证据级别I,推荐级别A)。为了阐明这个问题,有必要采用适当的技术进行进一步的试验。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号